Eran Nadav

Eran Nadav currently works at TPG Biotech, as Partner and Managing Director, Shangpharma Corp., as Director, Nutrinia Ltd., as Director, Tarrant Capital IP LLC, as Managing Director from 2007, Tevel Aerobotics Technologies Ltd., as Director, and Clexio Biosciences Ltd., as Director.
Dr. Nadav also formerly worked at Ultragenyx Pharmaceutical, Inc., as Chairman from 2013 to 2015, Collegium Pharmaceutical, Inc., as Director in 2015, NovaSom, Inc., as Director, Tamda Ltd., as Director from 2010 to 2011, JCR Pharmaceuticals Co., Ltd., as Director, MacroGenics, Inc., as Independent Director, Eisai, Inc., as Director-Business Development from 2003 to 2007, Eden Springs UK Ltd., as Director, Trevi Therapeutics, Inc., as Independent Director from 2012 to 2019, Fusion Pharmaceuticals, Inc., as Director, CTx Operations, Inc., as Director, Johnson & Johnson Innovation - JJDC, Inc., as Principal, Israel Defense Forces, as Principal, and Neurim Pharmaceuticals Ltd., as Principal.
Dr. Nadav received his undergraduate degree, graduate degree, Masters Business Admin degree, and doctorate degree from Tel-Aviv University.